GLP Watchdog

Push Health vs Ro

Neither Push Health nor Ro has an FDA warning letter on record. Push Health publishes no GLP-1 price we could capture. Ro starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Push Health / Ro

Push Health logo

Push Health

4.1/10

Ro logo

Ro

7.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
No GLP-1 price published
$149/moBrand-name semaglutide pill, medication only, membership extra
States
No state list published
All 50 states
Checked
Prices captured Record checked September 2026
Prices captured Record checked October 2026
Visit Push Health
Visit Ro

Neither Push Health nor Ro pays us. Links to them earn nothing. Scores: Push Health 4.1, Ro 7.4. How we are paid

What the record shows

  1. 01

    Neither Push Health nor Ro has an FDA warning letter on record.

  2. 02

    Push Health names no compounding pharmacy in our record. Ro sells brand-name medication only.

  3. 03

    Push Health publishes no GLP-1 price we could capture. Ro starts at $149 a month (medication only, membership extra) for brand-name semaglutide pill.

  4. 04

    Only Ro lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Ro lists all 50 states. Push Health publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Push Health

Ro

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Not stated
Clinician visits, labs, coaching
Billed separately
Not stated
Medication
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Refunds
Full refund if you cancel before the provider writes a prescription; none after
Membership fees are not refunded; the $39 first month is refunded if you are not eligible

Read off each seller’s own pages. Push Health: September 28, 2026. Ro: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Push Health

4.1/10

The record gives Push Health no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Publishes no GLP-1 price
Visit Push Health

The case for Ro

7.4/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Push Health does not price
  • Price leaves out medication
  • Lowest price covers the medication only, with a separate membership on top
Visit Ro

Scores

Push Health 4.1 · Ro 7.4 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

5.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

4.0A
vs
B
9.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

5.0A
vs
B
5.5

The score is the same formula for every seller. Payment does not enter it. Method

Push Health vs Ro: questions

Neither Push Health nor Ro has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Push Health names no compounding pharmacy in our record. Ro sells brand-name medication only.
Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after. Ro states you can cancel at any time; refunds: membership fees are not refunded; the $39 first month is refunded if you are not eligible.
Neither Push Health nor Ro pays us. Links to them earn nothing. Scores: Push Health 4.1, Ro 7.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks